Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0344307 (
analgesia
)
28,200
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent reports showed that
aquaporin 4
(
AQP4
) deficiency potentiated morphine
analgesia
but attenuated chronic morphine-induced tolerance in hot-plate test, predominantly reflecting supraspinal pain response. The present study investigated the effects of
AQP4
deficiency on morphine
analgesia
and tolerance using tail flick test, primarily reflecting spinal response. It was found that (1) chronic morphine treatment resulted in decreased expression of spinal
AQP4
in mice detected by Western blotting analysis; (2) in tail flick test,
AQP4
knockout mice displayed significant impaired morphine
analgesia
without influencing the progress of chronic tolerance; and (3) the expressions of mu-opioid receptor (MuOR) and glutamate transporter 1 (GLT-1) in
AQP4
knockout mice spinal cord were lower than those in wild-type mice, whereas chronic morphine-induced alteration characteristics of spinal MuOR or GLT-1 expression were not affected by
AQP4
deficiency. In conclusion,
AQP4
deficiency attenuated morphine acute antinociception but did not affect chronic tolerance in tail flick test, implying a role for spinal
AQP4
in morphine
analgesia
but not in chronic tolerance.
...
PMID:Effects of aquaporin 4 deficiency on morphine analgesia and chronic tolerance: a study at spinal level. 2038 9